-
Hyundai reaches tentative deal with workers after strike
-
STARTRADER Adds 30 U.S. Stock and ETF CFDs as 2026 Product Expansion Accelerates
-
Trees 'giving up': climate change hammers historic English gardens
-
Trees 'giving up': climnate change hammers historic English gardens
-
Malian songbird keeps age-old sounds alive at 88
-
Namibia paves way for phosphate mining in the Atlantic Ocean
-
Canada to announce response to Trump's new tariffs
-
Six months into Iran war, Hormuz traffic way down, sailors stranded
-
Stocks stagger and oil rises as traders eye Iran threat, Nvidia results
-
Netanyahu got his Iran war, but maybe not his desired result
-
Families of detained Chinese Christians cling to faith in legal limbo
-
Hyundai reaches tentative deal with workers after strikes
-
Trump veers from boredom to denial after six months of Iran war
-
Once its saviour, US puts Kuwait in Iran's crosshairs
-
Cool Japan: Human fridge chills workers in extreme heat
-
Australia's top music charts ban AI songs
-
Tens of thousands flee fire near US city of Reno
-
How the French language contributed to the US-Canada trade war
-
Despair and anger erupt after deadly Guinea landfill collapse
-
Nevada sues US govt over cuts to Colorado River access
-
Tornado tears through French village, dozens injured
-
'Special' Chelsea forwards inspire Alonso's winning start
-
Federer looks forward to brief return to Arthur Ashe stadium
-
Alonso makes winning start with Chelsea as Rogers scores on debut
-
US removes Syria from state sponsor of terrorism list
-
Oil prices fall as Bessent outlines new steps to punish Iran
-
Facebook, TikTok promoted Colombian armed groups' content to recruit children: HRW
-
Saudi Arabia to invest $7 bn in theme parks near Paris
-
Palmeiras agree to sell Allan to Manchester City: source
-
British PM Burnham hits a chord on Kyiv visit
-
US vows 'economic asphyxiation' of Iran with new sanctions
-
Saudi Arabia to invest $7 bn in theme parks near Paris: French presidency
-
French tourist dies after getting stuck in scorching Death Valley
-
Vuelta stage three abandoned in dangerous weather conditions
-
US proposes expanding UN Sudan arms embargo to entire country
-
Banned Vondrousova appeals doping suspension to CAS
-
Ceasefire verification mission heads to east DR Congo
-
Ukraine's allies pledge to continue support despite Russian threats
-
Carse dropped from England squad after nightclub incident
-
France readies high school phone ban for next month
-
Empire State Building climbers kiss outside court after viral proposal
-
Trump says to double tariffs on Canada autos as trade fight heats up
-
French poll shows Le Pen's biggest challenger may be hard left's Melenchon
-
Noosha Aubel: Hur mycket administrativt misslyckande tål Potsdam till?
-
Noosha Aubel: Πόση διοικητική αποτυχία μπορεί να αντέξει ακόμα το Πότσδαμ?
-
WeGolden Receives Best Gold Trading Platform Asia 2026 Recognition from TrustFinance Awards
-
WeMasterTrade Receives Best Instant Prop APAC 2026 Recognition from TrustFinance Awards
-
BtcDana Wins “Best Customer Support Experience – CFD Broker 2026” at the TrustFinance Performance Awards
-
MH Markets Recognized as Most Transparent Broker at the TrustFinance Awards 2026
-
Belgian pie-thrower, scourge of celebrities, dies at 80
'Pharma Bro' Shkreli released to halfway house in US
So-called "Pharma bro" Martin Shkreli has been released from a Pennsylvania prison to a halfway house in New York state, the US Bureau of Prisons said Wednesday.
Shkreli, who became a poster child for predatory pharmaceutical pricing before being convicted of securities fraud in 2017, was transferred Wednesday from a low-security prison in Allenwood, Pennsylvania to undisclosed "community confinement" in New York state, said a BOP spokesperson in an email.
He is scheduled to be released from BOP's custody on September 14, the spokesperson said.
Shkreli's attorney, Benjamin Brafman, confirmed the release, saying he was "pleased" to report that his client was let out early "after completing all programs that allowed for his prison sentence to be shortened," according to a statement.
"While in the halfway house I have encouraged Mr. Shkreli to make no further statement, nor will he or I have any additional comments at this time."
Once dubbed "the most hated man in America," Shkreli, 39, became infamous for suddenly raising the price of the HIV drug Daraprim in 2015 by 5,000 percent -- from $13.50 a pill to $750.
Shkreli was originally sentenced in 2018 to seven years in prison in a fraud case not directly related to the Daraprim matter. He has been in custody since September 2017.
J.V.Jacinto--PC